Bismuth-thiols as antiseptics for epithelial tissues, acute and chronic wounds, bacterial biofilms and other indications
申请人:Microbion Corporation
公开号:US10835510B2
公开(公告)日:2020-11-17
Compositions and methods, including novel homogeneous microparticulate suspensions, are described for treating acute wounds, chronic wounds and/or a wound or epithelial tissue surface that contains bacterial biofilm, including unexpected synergy between bismuth-thiol (BT) compounds and certain antibiotics, to provide topical formulations including antiseptic formulations, for management and promotion of wound healing and in particular infected wounds. Previously unpredicted antibacterial properties and anti-biofilm properties of disclosed BT compounds and BT compound-plus-antibiotic combinations are also described, including preferential efficacies of certain such compositions for treating gram-positive bacterial infections, and distinct preferential efficacies of certain such compositions for treating gram-negative bacterial infections.
本文描述了用于治疗急性伤口、慢性伤口和/或含有细菌生物膜的伤口或上皮组织表面的组合物和方法,包括新型均匀微粒悬浮液,包括铋硫醇(BT)化合物与某些抗生素之间意想不到的协同作用,以提供局部制剂,包括防腐制剂,用于管理和促进伤口愈合,特别是感染伤口。此外,还描述了已公开的 BT 化合物和 BT 化合物加抗生素组合物以前未曾预料到的抗菌特性和抗生物膜特性,包括某些此类组合物治疗革兰氏阳性细菌感染的优先功效,以及某些此类组合物治疗革兰氏阴性细菌感染的独特优先功效。